R. Dargahiyan (M. A); Sh. Mohammad Khani (Ph. D); J. Hassani (Ph. D); J Shams (Ph. D)
Volume 1, Issue 3 , February 2011, , Pages 81-104
Abstract
Metacognitive Therapy (MCT) is a new and emerging approach that focuses on reducing unhelpful cognitive processes and facilitating metacognitive styles of processing. The aim of this study was to investigate the efficacy of metacognitive therapy on improving of metacognitive beliefs, rumination, and ...
Read More
Metacognitive Therapy (MCT) is a new and emerging approach that focuses on reducing unhelpful cognitive processes and facilitating metacognitive styles of processing. The aim of this study was to investigate the efficacy of metacognitive therapy on improving of metacognitive beliefs, rumination, and depression symptoms of major depressive patient.
In a single case experiment with multiple baseline design a woman suffering from MDD were treated with eighth weekly sessions of MCT and antidepressant medications. Second woman with the same diagnostic a control case only received antidepressant medications. Instruments used in this research were included MDD-S, Metacognitive beliefs, (MCQ), Ruminative style (RRS), and Beck Depression Inventory (BDI-II).
Results indicated that metacognitive treatment result in improvement of subject's scores in Beck depression scale that reduced from 35 to 6 in posttest and 2 months follow up. The scores of scales of CAS and MDD-S showed remarkable reduction. But the control case who recived only antidepressant medications didn't show any significant changes in decrease of symptoms in follow up.
